news - International Biopharmaceutical Industry

Current Edition

news

FIND, DNDi to support Malaysian MoH for approaching HCV

It forms part of a larger FIND project known as Hepatitis C Elimination through Access to Diagnostics (HEAD-Start), supported by Unitaid. The Foundation for Innovat...

27 July 2018 news approaching | DNDi

Continue Reading →

news

Now your smartphone camera can perform clinical urinalysis at home

U.S. FDA Grants Landmark Class II Approval for Clinical Grade Smartphone Testing - Healthy.io’s Dip.io Urinalysis Israel based Healthy.io, the first company in the ...

27 July 2018 news camera | clinical

Continue Reading →

news

Strengthen efforts to immunize 5 million unvaccinated children: WHO

The WHO South-East Asia Region records about 37 million births every year, of them over 88% children are now getting three doses of diphtheria, pertussis and tetanus ...

20 July 2018 news

Continue Reading →

news

LeapFrog acquires majority stake in Ascent Meditech

The investment will tap into the rapidly growing $100 billion Indian healthcare market LeapFrog Investments ("LeapFrog"), the leading investor in companies that deli...

20 July 2018 news

Continue Reading →

news

Novotech partners with Asian Eye Institute

Under the terms of the MoU, the AEI will provide its professional and clinical trial expertise to Novotech managed studies. Asia-Pacific specialist CRO Novotech has...

20 July 2018 news

Continue Reading →

news

Trump’s Drug Plan Picks Up Momentum as Merck Lowers Some Prices

The Trump administration moved swiftly in the past 24 hours to implement pieces of its plan to bring down drug prices, preparing several significant steps as one of t...

20 July 2018 news Trump

Continue Reading →

news

Tecentriq misses another chance to catch Keytruda

A flurry of Phase 3 data this year from Roche's immmunotherapy Tecentriq has so far proved insufficient to erase the lead of Merck & Co.'s rival Keytruda in fi...

20 July 2018 news

Continue Reading →

news

Allergan’s eye drug stacks up against Lucentis, but wider market still iffy

Allergan on Thursday touted data from two late-stage trials that showed a drug it in-licensed from a Swiss biotech proved non-inferior to Lucentis in the treatment...

20 July 2018 news Allergan | Drug

Continue Reading →

news

Novartis picks up IL-17 inhibitor in deal worth over $1B

Novartis on Thursday inked a deal for development and commercialization rights to MOR106, an interleukin (IL)-17C inhibitor for the treatment of atopic dermatitis ...

20 July 2018 news Novartis

Continue Reading →

news

Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors

Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gam...

20 July 2018 news advance | announce

Continue Reading →